Quality, integrity and utility of COVID-19 science: opportunities for public health researchers.
作者信息
Pezzullo Angelo Maria, Ioannidis John P A, Boccia Stefania
机构信息
Section of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA.
出版信息
Eur J Public Health. 2023 Apr 1;33(2):157-158. doi: 10.1093/eurpub/ckac183.
Abstract
摘要
相似文献
1
Quality, integrity and utility of COVID-19 science: opportunities for public health researchers.新冠病毒科学的质量、完整性与实用性：公共卫生研究人员面临的机遇
Eur J Public Health. 2023 Apr 1;33(2):157-158. doi: 10.1093/eurpub/ckac183.
2
Using behavioural science in public health settings during the COVID-19 pandemic: The experience of public health practitioners and behavioural scientists.在 COVID-19 大流行期间将行为科学应用于公共卫生环境：公共卫生从业者和行为科学家的经验。
Acta Psychol (Amst). 2022 Apr;224:103527. doi: 10.1016/j.actpsy.2022.103527. Epub 2022 Feb 7.
3
Reflections On Governance, Communication, And Equity: Challenges And Opportunities In COVID-19 Vaccination.治理、沟通和公平的思考：COVID-19 疫苗接种的挑战与机遇
Health Aff (Millwood). 2021 Mar;40(3):419-425. doi: 10.1377/hlthaff.2020.02254. Epub 2021 Feb 4.
4
The COVID-19 Pandemic as an Opportunity to Ensure a More Successful Future for Science and Public Health.将新冠疫情作为确保科学和公共卫生拥有更成功未来的契机。
JAMA. 2021 Feb 9;325(6):525-526. doi: 10.1001/jama.2020.23479.
5
Public Health Messaging during the COVID-19 Pandemic and Beyond: Lessons from Communication Science.新冠疫情期间及之后的公共卫生信息传播：传播科学的启示。
Health Commun. 2022 Jan;37(1):1-19. doi: 10.1080/10410236.2021.1994910. Epub 2021 Nov 1.
6
COVID-19: opportunities for public health ethics?COVID-19：公共卫生伦理学的机遇？
J R Coll Physicians Edinb. 2021 Jun;51(S1):S47-S52. doi: 10.4997/JRCPE.2021.241.
7
Allocation of Opportunities to Participate in Clinical Trials during the Covid-19 Pandemic and Other Public Health Emergencies.在新冠疫情和其他突发公共卫生事件期间，分配参与临床试验的机会。
Hastings Cent Rep. 2022 Jan;52(1):51-58. doi: 10.1002/hast.1297. Epub 2021 Dec 15.
8
COVID-19 vaccination: science, politics and public health.新冠疫苗接种：科学、政治与公共卫生
J Am Dent Assoc. 2021 Mar;152(3):181-183. doi: 10.1016/j.adaj.2021.01.009. Epub 2021 Jan 21.
9
The COVID-19 pandemic in Australia: Public health responses, opportunities and challenges.澳大利亚的 COVID-19 大流行：公共卫生应对措施、机遇与挑战。
Int J Health Plann Manage. 2022 Jan;37(1):5-13. doi: 10.1002/hpm.3326. Epub 2021 Sep 7.
10
COVID-19 Case Investigation and Contact Tracing: Early Lessons Learned and Future Opportunities.COVID-19 病例调查和接触者追踪：早期经验教训和未来机会。
J Public Health Manag Pract. 2021 Jan/Feb;27 Suppl 1, COVID-19 and Public Health: Looking Back, Moving Forward:S87-S97. doi: 10.1097/PHH.0000000000001290.
引用本文的文献
1
Completeness and changes in data reporting pharmacological interventions to treat COVID-19.治疗新冠肺炎的药物干预措施数据报告的完整性与变化情况。
Sci Rep. 2025 Jul 2;15(1):22989. doi: 10.1038/s41598-025-06308-y.
2
A structured, journal-led peer-review mentoring program enhances peer review training.一个由期刊主导的结构化同行评审指导计划可加强同行评审培训。
Res Integr Peer Rev. 2024 Mar 8;9(1):3. doi: 10.1186/s41073-024-00143-x.
3
Effectiveness of and Inequalities in COVID-19 Epidemic Control Strategies in Hungary: A Nationwide Cross-Sectional Study.匈牙利新冠疫情防控策略的有效性及不平等性：一项全国性横断面研究
Healthcare (Basel). 2023 Apr 25;11(9):1220. doi: 10.3390/healthcare11091220.
本文引用的文献
1
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review.关于 COVID-19 的非药物干预措施的随机试验：范围综述。
BMJ Evid Based Med. 2022 Dec;27(6):334-344. doi: 10.1136/bmjebm-2021-111825. Epub 2022 Jan 27.
2
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
3
In search of the relevant COVID research.寻找相关的新冠病毒研究。
Eur J Public Health. 2020 Oct 1;30(5):850-851. doi: 10.1093/eurpub/ckaa169.
4
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
Zotero 插件